FATE1 (fetal and adult testis expressed 1) is an X-linked cancer-testis antigen that primarily functions as a negative regulator of endoplasmic reticulum (ER)-mitochondria coupling and apoptosis. At the molecular level, FATE1 localizes to mitochondria-associated ER membranes (MAMs) where it increases ER-mitochondria distance and suppresses calcium transfer from the ER to mitochondria 1. This uncoupling activity reduces mitochondrial calcium-dependent pro-apoptotic signaling. FATE1 may collaborate with the E3 ubiquitin ligase RNF183 to restrain levels of pro-apoptotic proteins like BIK and BNIP3L 2. In disease contexts, FATE1 expression is upregulated in multiple cancers including adrenocortical carcinoma, Ewing sarcoma, and breast cancer, where it promotes survival and chemotherapy resistance by preventing apoptosis 123. In hepatic metabolic disease, FATE1-mediated ER-mitochondria disruption impairs insulin signaling and promotes hepatic steatosis, demonstrating that organellar miscommunication is an early causal trigger of metabolic dysfunction 4. Clinically, FATE1 expression inversely correlates with survival in adrenocortical carcinoma patients and represents a prognostic biomarker in breast cancer 13, positioning it as a potential therapeutic target for cancer and metabolic disease.